CHICAGO—A 49-year-old woman has had RA for eight years. She has a rheumatoid factor reading of 35, an aCCP reading of 160, erythrocyte sedimentation rate of 42, plus erosions. She has been on methotrexate. She tried etanercept for six months, but then it stopped working. She was on 40 mg of adalimumab weekly, but it…
Search results for: rituximab
EULAR 2015: The Biology of Fatigue
ROME, Italy—Fatigue, a problem experienced frequently by patients with rheumatic diseases, is best thought of as a survival mechanism and as a single phenomenon, not a condition that comes in a variety of forms, an expert said in a session at EULAR 2015, the annual congress of the European League Against Rheumatism (EULAR). Gene Regulated…
2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA
Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
2014 ACR/ARHP Annual Meeting: Sjögren’s Complications
Tips to screen for, treat central or peripheral nervous system disorders, lymphoma in patients with Sjögren’s syndrome
Infliximab, Tocilizumab Can Help in Large Vessel Vasculitis
Case studies show some patients with LVV can achieve remission after treatment with biological agents
2014 ACR/ARHP Annual Meeting: Microbiota Power
Gut bacteria may hold clues to breakthrough rheumatic disease treatments
Seizures in Lupus
Case report highlights important twist to differential diagnosis of neuropsychiatric lupus
2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma
Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Has Technology Depersonalized the Art of Medical Teaching?
Video streaming, interactive learning, flipped classrooms, self-study replacing class lectures
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 41
- Next Page »